tirzepatide through LillyDirect
Last updated 2026-09-13 — the price on this page. Read and dated by Alex Seot.
Can you get tirzepatide through LillyDirect, and what does it cost?
LillyDirect supplies tirzepatide as the branded, FDA-approved product. halfrx records $299 a month all-in once titrated, read from its own published page on 2026-09-13. That is the maintenance figure rather than an introductory rate, because the starting dose is not the dose anyone stays on. It is not the only route: halfrx records 5 verified ways to buy tirzepatide, and 3 of them are cheaper — the lowest at $249 a month. Nothing sits on LillyDirect's public record here: no FTC action, no state action, no failing BBB grade and no matched FDA warning letter.
What LillyDirect gets right, and what it does not
Each line is read from a cited source rather than from a reviewer's impression, and these are LillyDirect's own — nothing here is shared with the other sellers of this molecule.
- +You buy from Eli Lilly itself. No telehealth membership, no cancellation policy to fight, no compounding pharmacy in the chain.
- +Zepbound vials from $299/mo at the starter dose against a $1,086 list price — the largest manufacturer discount in the category.
- +Foundayo (orforglipron) from $149 a month, the lowest self-pay price for a branded GLP-1 on this site, and a daily pill.
- +Tirzepatide delivers the strongest average weight loss of any approved molecule.
- −Lilly molecules only. If tirzepatide does not suit you, this channel has no semaglutide alternative.
- −No clinical program, coaching or side-effect management — it is a pharmacy, not a weight service.
- −Self-pay pricing is dose-scaled, so the $299 and $149 headlines are starter doses, not maintenance.
- −Both products price maintenance doses on a 45-day refill condition, and Lilly counts a month as 28 days — so the advertised figure is a floor that assumes you never lapse.
What tirzepatide does, on the trial evidence
SURMOUNT-1, Study 1 on the label, 72 weeks: 20.9% mean weight loss at 15 mg against 3.1% on placebo, intention-to-treat. It is the trial behind Zepbound, the approved product built on this molecule.
FDA status of the approved product: FDA approved for chronic weight management and obstructive sleep apnea, since 2023-11-08.
List price of the approved product is $1,086 a month, against $299 here — a gap of $787 a month, or $9,444 a year, which is the whole reason this route exists.
Which products tirzepatide is sold as, and what each costs direct
| Product | Direct price | Maintenance dose | Checked |
|---|---|---|---|
| Zepbound | $449 | 5 mg, 10 mg or 15 mg once weekly | 2026-08-19 |
| Mounjaro | $499 | 2.5 mg to 15 mg once weekly, set by blood sugar control | 2026-09-21 |
These products are priced differently direct, so LillyDirect's one figure, $299, does not stand for each of them.
What you are actually buying each month
Zepbound
One injection a week. The label reaches the maintenance dose in week 5, so the first 4 weeks are on a lower starting dose. An advertised starting price buys that dose, not the one you stay on, which is why the price above is the maintenance one.
| Weeks | Dose | Note |
|---|---|---|
| 1–4 | 2.5 mg | Initiation only. The label says in as many words that 2.5 mg is not approved as a maintenance dose. |
| 5–8 | 5 mg | The first dose that can be kept long term. |
| 9–12 | 7.5 mg | Optional. Increases come in 2.5 mg steps, no sooner than every 4 weeks. |
| 13–16 | 10 mg | A maintenance dose, and the lowest one approved for sleep apnea. |
| 17–20 | 12.5 mg | Optional. |
| 21 and on | 15 mg | Maximum. Reachable no earlier than week 21. |
Maintenance: 5 mg, 10 mg or 15 mg once weekly. FDA prescribing information for Zepbound (tirzepatide)
Mounjaro
One injection a week.
| Weeks | Dose | Note |
|---|---|---|
| 1–4 | 2.5 mg | Starting dose. |
| 5 and on | 2.5 mg → 15 mg | Raised in 2.5 mg steps, each held at least 4 weeks, only if glycemic control needs it. The August 2026 label dropped the fixed move to 5 mg at week 5 and the line that 2.5 mg is not a glycemic-control dose. |
Maintenance: 2.5 mg to 15 mg once weekly, set by blood sugar control. FDA prescribing information for Mounjaro (tirzepatide, diabetes label)
Why LillyDirect rather than the cheapest route
Computed for this seller against every other verified route to the same molecule, so it is a different answer on every one of these pages.
- Where it sits on price
- 4th of 5 verified routes, $50 a month above Noom Med at $249 — $600 over a year, which is the number the choice actually turns on.
- What only this route gives
- No other verified route here supplies the FDA-approved product. The cheaper figures are compounded copies, which is a different legal status rather than the same product for less.
- What the money buys besides the drug
- LillyDirect sells the medication only, filled against a prescription written elsewhere. There is no program around the drug to pay for.
Other verified routes to tirzepatide
The pages ranking for this question cover one seller. Cheapest first, each with the date it was read.
| Route | A month | What it is | Checked |
|---|---|---|---|
| Noom Med | $249 | compounded, not FDA approved | 2026-09-22 |
| Found | $289 | compounded, not FDA approved | 2026-09-22 |
| Henry Meds | $297 | compounded, not FDA approved | 2026-09-20 |
| Medvi | $299 | provider | 2026-09-14 |
Everything on LillyDirect
- LillyDirect price and terms →
- Is LillyDirect legit? →
- tirzepatide: every product and price →
- orforglipron: every product and price →
- Foundayo: the drug →
- Mochi Health: the seller →
- Henry Meds: the seller →
- Noom Med: the seller →
- PlushCare: the seller →
- Compounded tirzepatide: the drug →
- Eden: the seller →
- GoodRx for Weight Loss: the seller →
This page exists only where LillyDirect actually supplies tirzepatide in the same form the medication is sold in — sharing a molecule is not the same as selling the product. Every figure carries its source and the date it was read.